These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. [Dangerous errors due to similar names of diverse drugs]. Scanelli G Recenti Prog Med; 1993 Mar; 84(3):231. PubMed ID: 8465105 [No Abstract] [Full Text] [Related]
65. Generic products of antiepileptic drugs (AEDs): is it an issue? Bialer M Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324 [TBL] [Abstract][Full Text] [Related]
66. Drug nomenclature: suggestions for change. Pollett HF CMAJ; 1992 Nov; 147(10):1422. PubMed ID: 1423079 [No Abstract] [Full Text] [Related]
67. [Prescription of generic drugs in general practice. Results of a survey of general practitioners]. Simmenroth-Nayda A; Hummers-Pradier E; Ledig T; Jansen R; Niebling W; Bjerre LM; Kochen MM; Himmel W Med Klin (Munich); 2006 Sep; 101(9):705-10. PubMed ID: 16977394 [TBL] [Abstract][Full Text] [Related]
68. Drug nomenclature suggestions for change. Rutter P CMAJ; 1992 Nov; 147(10):1422. PubMed ID: 1423078 [No Abstract] [Full Text] [Related]
69. The art of prescribing: negotiating the decision of generic or branded medications. Grant M; Chapman M Intern Med J; 2015 Jul; 45(7):774-6. PubMed ID: 26134696 [TBL] [Abstract][Full Text] [Related]
70. AFP policy on using generic and brand names for drugs. McCauley J Am Fam Physician; 2004 Sep; 70(6):1031-2; discussion 1032. PubMed ID: 15456112 [No Abstract] [Full Text] [Related]
71. I Can PresCribE A Drug: mnemonic-based teaching of rational prescribing. Iglar K; Kennie N; Bajcar J Fam Med; 2007 Apr; 39(4):236-40. PubMed ID: 17401764 [No Abstract] [Full Text] [Related]
72. When is a brand a generic? In a contract with a PBM. Cahn LJ Manag Care; 2010 Sep; 19(9):21-5. PubMed ID: 20931886 [No Abstract] [Full Text] [Related]
73. [Development of the measures to evaluate the similarity of drug brand names]. Ohtani H; Takeda M; Imada Y; Sawada Y Yakugaku Zasshi; 2006 May; 126(5):349-56. PubMed ID: 16679743 [TBL] [Abstract][Full Text] [Related]
74. [Fifty years old and more patients' attitudes towards and experiences of generic substitution of prescription medicines]. Ringuier R; Rouquette A; Dagorne C; Garnier F; Fanello S Therapie; 2008; 63(1):11-7. PubMed ID: 18387271 [TBL] [Abstract][Full Text] [Related]
75. Failure to weigh patients in hospital: a medication safety risk. Hilmer SN; Rangiah C; Bajorek BV; Shenfield GM Intern Med J; 2007 Sep; 37(9):647-50. PubMed ID: 17714205 [TBL] [Abstract][Full Text] [Related]
77. Psychiatric drugs & trends. The "Brand Name" game. Dembicki EL J Psychiatr Nurs Ment Health Serv; 1968; 6(4):239-41. PubMed ID: 4298688 [No Abstract] [Full Text] [Related]
78. [Ensuring safe medication in the physician's office]. Niebling W MMW Fortschr Med; 2006 May; 148(19):44-5. PubMed ID: 16736706 [TBL] [Abstract][Full Text] [Related]
79. How do patients identify their drugs? Yelland MJ; Veitch PC Aust Fam Physician; 1989 Nov; 18(11):1441-5. PubMed ID: 2516718 [TBL] [Abstract][Full Text] [Related]
80. Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins. Tran YB; Frial T; Miller PS Can J Clin Pharmacol; 2007; 14(2):e205-14. PubMed ID: 17556788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]